but also within an individual based on the location of the wound. Therefore, the preparation of customized treatments for individual patients represents an important therapeutic goal in the fields of dermatology and wound healing. The objective of this study was to evaluate the usefulness of fatty acids found in pracaxi oil in a compounded topical anhydrous silicone base for wound and scar therapy. Results: A total of seven patients were considered available for analysis and were included in the study. In all seven cases, patients reported improvement in scar and wound attributes, including scar and wound size, severity, color, and pain associated with the scar or wound after application of the compounded medicine. On average, patients Electronic supplementary material The online version of this article (doi:10.1007/s13555-014-0065-y) contains supplementary material, which is available to authorized users.
INTRODUCTION
All wounds affect the integrity of the skin and can result in the imperfect, although normal, end point of tissue repair, namely, skin scarring.
Phenotypically, scars can range from a fine line to a variety of abnormal scars, including hypertrophic and keloid scars. While skin scarring is often considered trivial, it can be aesthetically unpleasant and disfiguring, and can cause distress and anxiety to the patient [1] . Scarring can also have physical consequences including tenderness, itching, and pain, which can be functionally disabling and can contribute to a diminished quality of life (reviewed in [2] ).
Currently, the therapeutic goal of wound and scar treatment is to reduce the severity of scars as much as possible. However, this is difficult as there is considerable qualitative and quantitative variability in skin scarring between individuals. A genetic predisposition to abnormal skin scarring has been demonstrated in certain ethnic populations [3] . In addition, scars can vary within an individual, as scars are normally more severe in certain locations of the body, including those with frequent movement. Consequently, a personalized approach to the clinical treatment of wounds and scars based on both the wound or scar attributes and the patient allows for improved treatment [2] [3] [4] . Compounding, the preparation of customized medications to meet the specific needs of individual patients, allows patients the benefit of a personalized treatment and represents an invaluable therapeutic alternative in dermatology [5] . Compounded medications may be personalized to include special combinations of active substances in particular concentrations, as well as to include specific raw materials or provide certain organoleptic characteristics adjusted to the patient's skin type and disorder [6] . The use of compounded topical formulations has already proven successful in wound care [7, 8] .
Pracaxi oil, derived from the seeds of the Pentaclethra macroloba tree indigenous to the Amazon, has several medicinal applications including the treatment of ulcers, stretch marks, bacterial infections, and snake bites [9, 10] . Pracaxi oil contains high amounts of oleic, linoleic, and behenic fatty acids, which are frequently utilized in the cosmetic industry [9] and have been shown to enhance wound closure and improve healing in several wound models [11, 12] . Fatty acids are integral to the formation and maintenance of cell membranes within the stratum corneum, the layer of the skin that provides a barrier to the environment and regulates permeability [13] . In addition, fatty acids have lubricant, emollient, and antiinflammatory properties, which help to restore the natural oils of the skin and protect the skin from environmental damage [14] .
Fatty acids have also been shown to enhance topical drug delivery of many active pharmaceutical ingredients, including waterand oil-soluble products [15] . However, topical application of fatty acids, especially unsaturated fatty acids such as oleic acid, can irritate the skin [16] . Pracaxi oil contains high levels of behenic acid and oleic acid, and has been used topically by native Amazonians to treat a variety of diseases [17] . In this case series, the healing properties of pracaxi oil in a compounded topical anhydrous silicone base were examined in patients with surgical, traumatic, moisture-associated, or burn-related wounds and scars. We hypothesized that incorporation of pracaxi oil 
RESULTS
Of the 21 patients enrolled in the case series, 7
completed the patient self-report questionnaire and had clinical photographs for consideration and review. The seven patients ranged in age from 5 months to 72 years and had a variety of wound types including surgical, traumatic, burn, and moisture-associated wounds ( Table 1 ). The mean duration of application of the compounded topical anhydrous base containing pracaxi oil was 11 days [standard deviation (SD) 6.11 days], ranging from 48 h to 3 weeks based on the size and severity of the wound or scar.
Overall patient satisfaction with the use of compounded topical anhydrous silicone base containing pracaxi oil alone, or in combination with other active substances, was high. Using the patient self-report questionnaire to rate satisfaction on a scale from 1 to 10, patients reported a mean score of 10 (SD 1.15) following application. In addition, no adverse effects were reported to the pharmacist or investigator during the course of the study.
Retrospective dermatological review of patients' wounds and scars also revealed clinical improvement in the wound or scar attributes over time following application of the compounded topical anhydrous silicone base containing pracaxi oil with or without active pharmaceutical substances. Of the seven patient photographs reviewed, six wounds/scars were considered to be ''much improved'' when compared with their respective baseline images and one wound/scar, which was treated with topical base containing pracaxi oil alone, was considered to be ''improved'' compared with baseline. No wounds or scars were considered to be ''neutral'', ''worse'', or ''much worse'' after application compared with baseline (Fig. 1) . The individual compounded topical medications applied and the outcomes of each patient are described in detail in the following sections. Characteristics, wound/scar attributes, and application regimen F female, M male Fig. 1 Photographs of wounds and scars were taken at baseline (prior to application of compounded topical anhydrous silicone base containing pracaxi oil) and at the end of the application period. Photographs were retrospectively reviewed by an independent dermatological reviewer who graded the changes in wounds/scars from baseline to the end of the application period using a scale of ' 'much worse' ', ' 'worse' ', ' 'neutral' ', ' 'improved' ', and ' 'much improved' ' underwent osteochondral allograft surgery for the second time. The patient was advised to wait 10 days after removal of the stitches before applying any topical medication. After 10 days, the patient initiated application of the topical anhydrous silicone base containing pracaxi oil, with no additional active substances, twice daily (Fig. 2a) . Following 2 weeks of application, the thickness of the surgical scar was visibly reduced (Fig. 2b) , and the wound was graded as ''much improved''. The patient reported drastic improvement in the feel and size of the scar, and noted less irritation in the area.
Case 2: Pre-existing Surgical Ankle Scar
A 57-year-old female with type I diabetes underwent 3 reconstructive surgeries following a fractured ankle. These surgeries resulted in 3 ankle scars, including one hypertrophic scar. Prior to this study, the patient had applied several different products to the scars, but still experienced itching associated with the hypertrophic scar and was generally not satisfied with the aesthetics of the scar (Fig. 3a) . One year after her last surgery, the patient began application of compounded topical anhydrous silicone base containing pracaxi oil, without additional active substances, twice daily to the hypertrophic scar. Following 1 week of application, the patient reported that the overall severity as well as the thickness and coloration of the scar were considerably improved (Fig. 3b) , and the scar was graded as ''much improved''.
Case 3: New Radiation Burn
A 72-year-old male underwent a surgical removal procedure and 33 sessions of radiation therapy on the right side of the head and neck to treat acinic cell carcinoma. The patient experienced radiation burns at the site of treatment with extremely sensitive, dry, and scaly skin resulting in extreme pain and discomfort (Fig. 4a) . Topical compounded anhydrous silicone base containing pracaxi oil without additional active ingredients was applied to the radiation burn 4 times daily, or as needed to relieve discomfort. Following 4 days of application, the patient acknowledged significant healing and tissue regrowth. By day 10, the radiation burn was almost completely healed and pain free, and on day 14, the skin was smooth, soft, and pink and the patient reported that he was pain free (Fig. 4b) . The burn was considered ''much improved'' by an independent dermatology reviewer.
Case 4: Pediatric Diaper Rash
The guardians of a 15-month-old female suffering from diaper rash, a moistureassociated skin condition, had previously treated the patient with several over-thecounter topical products without success. The condition worsened with time, resulting in increased pain and discomfort for the child (Fig. 5a ). Application of compounded topical anhydrous silicone base containing pracaxi oil (without additional active ingredients) was recommended two to four times daily at diaper change. After 48 h of application, the diaper rash had improved (Fig. 5b) and the toddler no longer appeared to experience pain or discomfort. The rash was considered ''improved'' from baseline by an independent dermatology reviewer.
Case 5: Pediatric Facial Burn
A 5-month-old female was severely scalded with liquid on the face, resulting in a major second degree burn (Fig. 6a) . Following the incident, compounded topical anhydrous silicone base containing pracaxi oil without additional active ingredients was applied twice daily to the burn, with sterile bacitracin ointment to prevent infection. After 8 days of application, the infant's facial wound healed completely with no evidence of scarring (Fig. 6b) . The burn was considered ''much improved'' from baseline after the application of compounded anhydrous silicone base containing pracaxi oil.
Case 6: Pre-existing Facial Scars
A 22-year-old female was left severely scarred on the face following a car accident. The patient had undergone six plastic surgery procedures and had previously used several treatments to lessen scar formation. However, she was still unsatisfied with her facial scars and overall complexion (Fig. 7a) . Four years after the accident occurred, the patient began application of a medicine containing 1% pentoxifylline (a collagen and wound contraction inhibitor), 1% caffeine (to increase blood flow to the area), and 1% tranilast Fig. 5 Diaper rash on a 15-month-old child a before and b 48 h after application of compounded base containing pracaxi oil Fig. 6 A second degree facial burn on the face of a 5-month-old infant a before and b 8 days after application of compounded base containing pracaxi oil Fig. 7 Pre-existing facial scars following traumatic injury and plastic surgery a before and b 3 weeks after application of a compounded medicine comprising 1% pentoxifylline, 1% caffeine, and 1% tranilast in a topical anhydrous silicone base containing pracaxi oil (a collagen synthesis inhibitor) in topical compounded anhydrous silicone base containing pracaxi oil. The compounded medicine was applied twice daily to the facial scars. After 3 weeks of application, there was an overall improvement in the severity of the scars and the patient reported that the skin around the scar was softer and that the redness of the scar had decreased (Fig. 7b) . The scars were considered ''much improved'' from baseline following application of the compounded medicine.
Case 7: Multiple Elbow Wounds
A 40-year-old female fell on both elbows and was painfully injured as a result of repeated impact with the ground during a fitness competition.
Multiple layers of skin were scraped off and the patient presented with open wounds on the right and left elbows (Fig. 8a, b) .
The patient was instructed to apply a compounded medication containing 2% mupirocin in compounded topical anhydrous silicone base containing pracaxi oil three times a day. Mupirocin 2% was added to the compounded base to prevent bacterial contamination of the wounds. After 11 days of application, the wounds on both the right and left elbows were completely closed and the patient reported fast improvement in the use of her elbows (Fig. 8c, d ). The wounds were considered ''much improved'' from baseline following application of the compounded medicine.
DISCUSSION
The ability to create personalized treatments for the management of wounds and scarring is a particularly attractive premise, as it enables therapies to be tailored to the management of A recent gas chromatography analysis of pracaxi oil demonstrated that the oil is comprised of approximately 53% oleic acid, 26% linoleic acid, and 5% behenic acid [18] , all of which are known to enhance wound closure and improve healing in several wound models [11, 12] . In addition, these fatty acids are known to enhance permeation of the outer layers of the skin, allowing for faster targeted delivery of water-and oil-soluble active pharmaceutical ingredients. [19, 20] , were added to the compounded medicine for one patient. As collagen is the major protein deposited during scar formation, inhibition of its synthesis leads to decreased scar formation. Caffeine was also added to the compounded medicine to increase the flow of blood to the area and to aid in healing. In another patient, the bactericidal agent mupirocin was compounded with the topical anhydrous silicone base containing pracaxi oil to prevent infection. The ability to add these types of active ingredients to this base may allow for the treatment of more severe and more complex lesions, such as burns and diabetic ulcers.
Among patients with no known underlying comorbidities, pracaxi oil used alone or in combination with other active ingredients in a compounded topical anhydrous silicone base was effective in aiding wound healing and preventing or improving scars. Positive effects were seen after application in several different types of wounds including surgical, traumatic, and burn wounds. In particular, improvements in bilateral traumatic wounds of the elbow were observed in one patient. The skin of the dorsal elbow is characterized by high mobility to enable flexion and extension of the elbow during everyday use and is an area known to be particularly difficult to treat [21] .
Compounded topical anhydrous silicone base containing pracaxi oil was also effective in treating two pediatric patients: one with severe burns on the face and one with extensive diaper rash. These findings were in agreement with those from a randomized, double-blind, placebo-controlled pilot trial of a compounded topical anhydrous silicone base containing pracaxi oil in 11 adult volunteers with existing surgical, traumatic, or acne-related scarring.
Patients treated with a compounded topical anhydrous silicone base containing pracaxi oil had a greater mean percent improvement from baseline in scar length, scar color, pigment intensity, contour analysis, and texture or smoothness after 8 weeks of treatment when compared with patients treated with placebo (standard moisturizer) [22] . Together with the case series described here, these results suggest that the addition of pracaxi oil to a compounded topical anhydrous silicone base leads to qualitative and quantitative improvements in wound and scar attributes.
Overall satisfaction with this compounded base was high among all patients. During the study, no patients reported any adverse effects after application of compounded base containing pracaxi oil, demonstrating that this topical therapy is well tolerated in adults and children. 
